Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xenadrine is a prominent brand of weight loss and energy supplements that operates as a subsidiary of Iovate Health Sciences. Originally developed by Cytodyne Technologies, the brand gained significant market share in the late 1990s and early 2000s for its thermogenic formulas. The product line currently focuses on dietary supplements containing caffeine, herbal extracts, and vitamins designed to support metabolism and weight loss. Xenadrine products are distributed globally through major retail pharmacies, health food stores, and e-commerce platforms. The brand is a key player in the over-the-counter nutraceutical industry, specifically within the weight management segment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xenadrine.